DMAAR
Drugs Made In America Acquisition Corp Rights
DMAAR
DMAAR
32 hedge funds and large institutions have $7.1M invested in Drugs Made In America Acquisition Corp Rights in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$158K | |
| 2 | +$107K | |
| 3 | +$67.4K | |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$60.4K |
| 5 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$59.1K |
Top Sellers
| 1 | -$176K | |
| 2 | -$132K | |
| 3 | -$106K | |
| 4 |
HCM
Heights Capital Management
San Francisco,
California
|
-$64K |
| 5 |
CF
Cantor Fitzgerald
New York
|
-$60.1K |
